Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant

Thrombosis Research

Volumn 143, Issue , 2016, Pages 137-140

  Arachchillage, Deepa R J ^a   Besser, Martin ^b   Maclean, Rhona ^a   Baglin, Trevor ^b   Van Veen, Joost J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Apixaban; Argatroban; Cancer; Dabigatran; Recurrent venous thrombosis; Rivaroxaban

Indexed keywords

ANTICOAGULANT AGENT; APIXABAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; DABIGATRAN; FONDAPARINUX; PROTHROMBIN A; RIVAROXABAN; ANTITHROMBIN; ARGATROBAN; LOW MOLECULAR WEIGHT HEPARIN; PIPECOLIC ACID DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE;

ADULT; AGED; ANTICOAGULATION; CANCER PATIENT; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; LETTER; LIVER METASTASIS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; RECURRENT DISEASE; SMALL CELL LUNG CANCER; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR THROMBUS; VENOUS THROMBOEMBOLISM; CASE REPORT; COMPLICATION; NEOPLASM; VENOUS THROMBOSIS;

ADULT; AGED; ANTICOAGULANTS; ANTITHROMBINS; DABIGATRAN; FACTOR XA INHIBITORS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PIPECOLIC ACIDS; PYRAZOLES; PYRIDONES; RECURRENCE; RIVAROXABAN; VENOUS THROMBOSIS;

EID: 84971278480     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2016.05.007     Document Type: Letter

References (12)

1. N. van Es, M. Coppens, S. Schulman, S. Middeldorp, and B. HR Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials Blood 124 2014 1968 1975
2. A.Y. Lee, M.N. Levine, R.I. Baker, C. Bowden, A.K. Kakkar, M. Prins, and et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N. Engl. J. Med. 349 2003 146 153
3. H.R. Buller, F.F. van Doormaal, G.L. van Sluis, and P.W. Kamphuisen Cancer and thrombosis: from molecular mechanisms to clinical presentations J. Thromb. Haemost. 5 Suppl. 1 2007 246 254
4. G.H. Lyman, and A.A. Khorana Cancer, clots and consensus: new understanding of an old problem J. Clin. Oncol. 27 2009 4821 4826
5. M. Carrier, A.A. Khorana, J. Zwicker, S. Noble, and A.Y. Lee Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH J. Thromb. Haemost. 11 2013 1760 1765
6. H.G. Watson, D.M. Keeling, M. Laffan, R.C. Tait, and M. Makris Guideline on aspects of cancer-related venous thrombosis Br. J. Haematol. 170 2015 640 648
7. A.R. Pillai, A. Olujohungbe, M.R. Evans, N.J. Main, and B.J. Hunt The management of recurrent VTE in cancer patients receiving therapeutic anticoagulation: the use of dual anticoagulant therapy combined with an IVC filter Blood Coagul. Fibrinolysis 21 2010 766 769
8. J. Beyer-Westendorf, S. Werth, G. Folprecht, and N. Weiss Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux Br. J. Clin. Pharmacol. 72 2011 715 716
9. M. Carrier, G.G. Le, R. Cho, S. Tierney, M. Rodger, and A.Y. Lee Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients J. Thromb. Haemost. 7 2009 760 765
10. G.H. Lyman, A.A. Khorana, N.M. Kuderer, A.Y. Lee, J.I. Arcelus, E.P. Balaban, and et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update J. Clin. Oncol. 31 2013 2189 2204
11. M. Carrier, A. Lazo-Langner, S. Shivakumar, V. Tagalakis, P.L. Gross, N. Blais, and et al. Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendations Curr. Oncol. 22 2015 49 59
12. M.A. Smythe, J. Priziola, P.P. Dobesh, D. Wirth, A. Cuker, and A.K. Wittkowsky Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism J. Thromb. Thrombolysis 41 2016 165 186